title: Azacytidine treatment after discontinuation of immunosuppressants in patients with myelodysplastic syndrome and relapse after allo-SCT at a single center.
authors.forename: S-Y
authors.initials: SY
authors.lastname: Kim
authors.forename: S-G
authors.initials: SG
authors.lastname: Cho
authors.forename: B-S
authors.initials: BS
authors.lastname: Cho
authors.forename: M-S
authors.initials: MS
authors.lastname: Kim
authors.forename: K-S
authors.initials: KS
authors.lastname: Eom
authors.forename: Y-J
authors.initials: YJ
authors.lastname: Kim
authors.forename: H-J
authors.initials: HJ
authors.lastname: Kim
authors.forename: S
authors.initials: S
authors.lastname: Lee
authors.forename: C-K
authors.initials: CK
authors.lastname: Min
authors.forename: D-W
authors.initials: DW
authors.lastname: Kim
authors.forename: J-W
authors.initials: JW
authors.lastname: Lee
authors.forename: W-S
authors.initials: WS
authors.lastname: Min
mesh_terms: D000328:Adult; D001374:Azacitidine / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000473:pathology; D010865:Pilot Projects; D012008:Recurrence; D016879:Salvage Therapy / Q000379:methods*; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D001374:Azacitidine